A CANCER jab available on the NHS can melt away tumours when patients have run out of options, a trial found. Triple-action injection amivantamab works by blocking a growth protein and an enzyme ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one agent shown to shrink tumors in patients whose disease had resisted every ...

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune ...

The treatment reprograms T cells to hunt down a patient's cancer. The approach could speed treatment and cut costs, but needs more study. With just a single injection, a new treatment transforms ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...